论文信息 - FDA Approval Summary: Selinexor for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. - 字舞流文

FDA Approval Summary: Selinexor for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

R. Pazdur | Y. Kasamon | M. Theoret | Lauren S. L. Price | Ruo-Jing Li | N. Gormley | Nicholas C Richardson | O. Okusanya | Yu-te Wu | Lian Ma | Nicholas Richardson